CONCLUSION
In conclusion, 47.3 % of ICU patients at MM had a clinically significant DDIs, and ICU patients at MM had lower rates of DDIs than patients at KTH, likely due to the presence of EMR based screening. Additional studies at a variety of units and institutions are needed to determine the relative effectiveness of EMR-based screening tools and pharmacists. Outcome studies are also needed to validate that clinically relevant DDIs have meaningful effects on patient outcomes. Finally, improvements are needed to EMR-based DDI screening tools and systems to detect and manage DDIs to ensure all patients receive safe and effective treatment.